Insider · CIK 0001772399

Baker Brian Lee

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001772399

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-23	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+1,298 sh	$3.20	+$4,153.6	17,318
2021-03-23	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+4,545 sh	$5.12	+$23.3K	21,863
2021-03-23	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+10.7K sh	$7.43	+$79.4K	32,551
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−4,919 sh	$97.89	−$482K	27,632
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−4,459 sh	$98.76	−$440K	23,173
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−1,996 sh	$100.07	−$200K	21,177
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−5,010 sh	$100.98	−$506K	16,167
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−8,061 sh	$102.23	−$824K	8,106
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−3,890 sh	$102.84	−$400K	4,216
2021-03-23	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−100 sh	$104.17	−$10.4K	4,116
2021-03-23	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−11.9K sh	—	—	2,165
2021-03-23	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−4,545 sh	—	—	6,494
2021-03-23	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−10.7K sh	—	—	19,668
2021-03-23	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+11.9K sh	$2.19	+$26.1K	16,020
2021-03-23	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−1,298 sh	—	—	0
2021-03-22	Turning Point Therapeutics, Inc.A Award	SVP of Finance and Admin.	AAward	+1,625 sh	—	—	4,116
2021-02-08	Turning Point Therapeutics, Inc.A Award	SVP of Finance and Admin.	AAward	+1,483 sh	—	—	2,491
2021-02-08	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	SVP of Finance and Admin.	AAward	+6,675 sh	—	—	6,675
2021-01-07	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+1,299 sh	$3.20	+$4,156.8	17,012
2021-01-07	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+11.9K sh	$2.19	+$26.1K	15,713
2021-01-07	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+4,545 sh	$5.12	+$23.3K	21,557
2021-01-07	Turning Point Therapeutics, Inc.M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	+10.7K sh	$7.43	+$79.4K	32,246
2021-01-07	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−2,800 sh	$122.65	−$343K	29,446
2021-01-07	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−900 sh	$120.16	−$108K	28,546
2021-01-07	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−5,200 sh	$121.57	−$632K	23,346
2021-01-07	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−21.8K sh	$122.44	−$2.67M	1,521
2021-01-07	Turning Point Therapeutics, Inc.S Sale	SVP of Finance and Admin.	SSale	−513 sh	$123.02	−$63.1K	1,008
2021-01-07	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−11.9K sh	—	—	14,069
2021-01-07	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−1,299 sh	—	—	1,298
2021-01-07	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−4,545 sh	—	—	11,039
2021-01-07	Turning Point Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP of Finance and Admin.	MExercise/Conversion	−10.7K sh	—	—	30,356
2020-01-06	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	SVP of Finance and Admin.	AAward	+50K sh	—	—	50,000
2019-12-10	Turning Point Therapeutics, Inc.A Award	SVP of Finance and Admin.	AAward	+216 sh	$31.13	+$6,723.432	3,016
2019-04-22	Turning Point Therapeutics, Inc.P Purchase	SVP of Finance and Admin.	PPurchase	+2,800 sh	$18.00	+$50.4K	2,800

Recent filings

Accepted (ET)
Mar 244
Baker Brian Lee0001209191-21-022949
SEC(opens sec.gov)
Feb 104
Baker Brian Lee0001209191-21-009360
SEC(opens sec.gov)
Jan 84
Baker Brian Lee0001209191-21-002840
SEC(opens sec.gov)

Companies

Turning Point Therapeutics, Inc.SVP of Finance and Admin.

Address

C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 225

SAN DIEGO, CA, 92121